These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15730048

  • 1. No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2005 Feb; 63(2):74-9. PubMed ID: 15730048
    [Abstract] [Full Text] [Related]

  • 2. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
    [Abstract] [Full Text] [Related]

  • 3. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.
    Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N.
    Clin Pharmacol Ther; 2000 Apr; 67(4):427-31. PubMed ID: 10801253
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal disease.
    Yasuda G, Kuji T, Hasegawa K, Ogawa N, Shimura G, Ando D, Umemura S.
    Ren Fail; 2004 Jul; 26(4):411-8. PubMed ID: 15462110
    [Abstract] [Full Text] [Related]

  • 5. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Jul; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 6. Effects of combined prednisone + fluvastatin on cholesterol and bilirubin in pediatric patients with minimal change nephropathy.
    Song M, Li A, Gong J, Yang D, Ma L, Zhou X, Yan Y, Xie Y.
    Clin Ther; 2013 Mar; 35(3):286-93. PubMed ID: 23485078
    [Abstract] [Full Text] [Related]

  • 7. STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D.
    Ertugrul DT, Yavuz B, Cil H, Ata N, Akin KO, Kucukazman M, Yalcin AA, Dal K, Yavuz BB, Tutal E.
    Cardiovasc Ther; 2011 Apr; 29(2):146-52. PubMed ID: 20370794
    [Abstract] [Full Text] [Related]

  • 8. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
    Plosker GL, Wagstaff AJ.
    Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
    [Abstract] [Full Text] [Related]

  • 9. Fluvastatin increases bone mineral density in postmenopausal women.
    Gotoh M, Mizuno K, Ono Y, Takahashi M.
    Fukushima J Med Sci; 2011 Mar; 57(1):19-27. PubMed ID: 21701079
    [Abstract] [Full Text] [Related]

  • 10. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
    Holdaas H, Jardine AG, Wheeler DC, Brekke IB, Conlon PJ, Fellstrøm B, Hammad A, Holme I, Isoniemi H, Moore R, Rowe PA, Sweny P, Talbot DA, Wadstrøm J, Østraat Ø.
    Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
    [Abstract] [Full Text] [Related]

  • 11. Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.
    Hartner A, Klanke B, Cordasic N, Amann K, Schmieder RE, Veelken R, Hilgers KF.
    J Hypertens; 2009 Feb; 27(2):376-85. PubMed ID: 19226708
    [Abstract] [Full Text] [Related]

  • 12. Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET).
    Inoue T, Ikeda H, Nakamura T, Abe S, Taguchi I, Kikuchi M, Toyoda S, Miyazono M, Kishi T, Sanai T, Node K.
    Intern Med; 2011 Feb; 50(12):1273-8. PubMed ID: 21673461
    [Abstract] [Full Text] [Related]

  • 13. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
    Desai P, Helkin A, Odugbesi A, Stein J, Bruch D, Lawler J, Maier KG, Gahtan V.
    J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy.
    Yang Z, Su Z, DeWitt JP, Xie L, Chen Y, Li X, Han L, Li D, Xia J, Zhang Y, Yang Y, Jin C, Zhang J, Li S, Li K, Zhang Z, Qu X, He Z, Chen Y, Shen Y, Ren M, Yuan Z.
    EBioMedicine; 2017 May; 19():49-59. PubMed ID: 28454732
    [Abstract] [Full Text] [Related]

  • 15. Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.
    Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Fenwick FI, Thomas HC, Neely RD, Taylor-Robinson SD, Bassendine MF.
    Liver Int; 2014 May; 34(5):737-47. PubMed ID: 24118830
    [Abstract] [Full Text] [Related]

  • 16. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P, Wu X, Shui H, Jia R.
    J Nephrol; 2013 May; 26(2):289-96. PubMed ID: 22641573
    [Abstract] [Full Text] [Related]

  • 17. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH, Wang Y, Dong B, Sun SZ, Chen Y, Meng XH, Liu ZZ.
    Chin Med J (Engl); 2005 Apr 20; 118(8):621-6. PubMed ID: 15899115
    [Abstract] [Full Text] [Related]

  • 18. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

  • 19. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, Branzi A, Shepherd J, Suryapranata H, de Feyter PJ, Melkert R, van Es GA, Pfister PJ.
    Eur Heart J; 1999 Jan 29; 20(1):58-69. PubMed ID: 10075142
    [Abstract] [Full Text] [Related]

  • 20. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
    Gürgün C, Ildizli M, Yavuzgil O, Sin A, Apaydin A, Cinar C, Kültürsay H.
    Int J Cardiol; 2008 Jan 11; 123(2):102-7. PubMed ID: 17320212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.